These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20799027)

  • 1. [(3)H]-F13640, a novel, selective and high-efficacy serotonin 5-HT(1A) receptor agonist radioligand.
    Heusler P; Palmier C; Tardif S; Bernois S; Colpaert FC; Cussac D
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):321-30. PubMed ID: 20799027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.
    Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
    Psychopharmacology (Berl); 2012 May; 221(2):261-72. PubMed ID: 22147258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
    J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S 14506: novel receptor coupling at 5-HT(1A) receptors.
    Milligan G; Kellett E; Dacquet C; Dubreuil V; Jacoby E; Millan MJ; Lavielle G; Spedding M
    Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S; Sallés J
    Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.
    Newman-Tancredi A; Martel JC; Assié MB; Buritova J; Lauressergues E; Cosi C; Heusler P; Bruins Slot L; Colpaert FC; Vacher B; Cussac D
    Br J Pharmacol; 2009 Jan; 156(2):338-53. PubMed ID: 19154445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile.
    Newman-Tancredi A; Assié MB; Martel JC; Cosi C; Slot LB; Palmier C; Rauly-Lestienne I; Colpaert F; Vacher B; Cussac D
    Br J Pharmacol; 2007 May; 151(2):237-52. PubMed ID: 17375087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.
    Picard M; Morisset S; Cloix JF; Bizot JC; Guerin M; Beneteau V; Guillaumet G; Hevor TK
    Neuroscience; 2010 Sep; 169(3):1337-46. PubMed ID: 20580787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.
    Watson J; Collin L; Ho M; Riley G; Scott C; Selkirk JV; Price GW
    Br J Pharmacol; 2000 Jul; 130(5):1108-14. PubMed ID: 10882396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
    Newman-Tancredi A; Rivet JM; Cussac D; Touzard M; Chaput C; Marini L; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):188-99. PubMed ID: 12923612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
    Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
    Jastrzębska-Więsek M; Wesołowska A; Kołaczkowski M; Varney MA; Newman-Tancredi A; Depoortere R
    Behav Pharmacol; 2022 Aug; 33(5):333-341. PubMed ID: 35695543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.
    Thomas DR; Atkinson PJ; Ho M; Bromidge SM; Lovell PJ; Villani AJ; Hagan JJ; Middlemiss DN; Price GW
    Br J Pharmacol; 2000 May; 130(2):409-17. PubMed ID: 10807680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bell-shaped agonist activation of 5-HT
    Newman-Tancredi A; Cussac D; Ormière AM; Lestienne F; Varney MA; Martel JC
    Cell Signal; 2019 Nov; 63():109383. PubMed ID: 31376526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT
    Newman-Tancredi A; Martel JC; Cosi C; Heusler P; Lestienne F; Varney MA; Cussac D
    J Pharm Pharmacol; 2017 Sep; 69(9):1178-1190. PubMed ID: 28612503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.